Allergy Diagnostics Market Report
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
This report, from Stratview Research, studies the clinical dianostics market - allery over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
The Burning Questions This Report Will Answer:
Some of the common tests that are available with today’s physicians are skin-prick testing, intradermal testing, and oral for confirmatory allergy testing. These tests are critical where the history describes serious allergic reactions; risk assessments based on historical descriptions alone are not reliable. Most of these tests are usually performed under specialized hands in speciality clinics, because, positive test results are less likely to be determined as the time period increases.
As we are moving towards a digital healthcare market, products such as Allergy Amulet, which is a portable device that can detect food allergens or certain ingredients is expected to be available in some markets by mid-2019. Each strip costs $1 to $3 and the reader will cost between $100 to $250 and can easily detect allergies from milk, soy, dairy, shellfish, finned fish, wheat, eggs and nuts.
Many multinational and domestic companies are present in this highly attractive segment. Companies with the US Headquarter are Thermo Fisher Scientific Inc., Danaher Corporation, HYCOR Biomedical, Lincoln Diagnostics Inc., Indoor Biotechnologies Inc. while the majority of key players are from Germany and the UK such as Siemens AG, Omega Diagnostics (UK), Stallergenes Greer (UK), R-Biopharma AG (Germany) and more. Majority of key players are based out of the US, Germany, the UK, China and Japan and control >90-94%% of the market globally.
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
Global Clinical Dianostics Market -Allergy is segmented into the following categories:
By Type of Test
By End User
With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:
Custom Research: Stratview research offers custom research services across sectors. In the case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].